Viewing Study NCT02516618


Ignite Creation Date: 2025-12-25 @ 4:59 AM
Ignite Modification Date: 2026-04-14 @ 12:37 AM
Study NCT ID: NCT02516618
Status: COMPLETED
Last Update Posted: 2016-05-12
First Post: 2015-07-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Fasinumab (REGN475) in Healthy Japanese and Caucasian Subjects
Sponsor: Regeneron Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module